BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company ...

Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...

Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine ...

Povorcitinib 75 mg achieved high-threshold lesion clearance by week 12, including 100% draining-tunnel reduction in 12%–57% and total abscess clearance in 22%–62% of participants. Phase 3 data show ...

An international research group has examined how many people are affected by preclinical and clinical obesity and what health ...

Studies highlight the clinical effectiveness of EXPAREL for total knee arthroplasty and long-term pain management with ioveraº for patients with osteoarthritis (OA) of the knee -- ...

Kymera Therapeutics remains focused on pipeline progression despite a Q4 revenue miss and widening net loss, supported by a robust $1.6 billion cash position. R&D investment surged to $316.6 million ...

Can you leave a clinical trial early? Learn your rights, what happens if you withdraw, and how to exit safely without affecting your medical care.

Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

Congenital aniridia is a rare disease caused, in most cases, by mutations in the PAX6 gene, which is essential for the ...

A key advantage of using RWD in a natural history study is gaining diverse and representative data. RWD covers broad patient populations, including those with comorbidities, various age groups, and ...

Based on this research output, EYEREUM Eye Clinic currently participates as a member institution of the Korean Ophthalmological Society’s LASIK and LASEK Committee, which reviews clinical ...